Allotment

KRM Ayurveda Ltd. has filed its Draft Red Herring Prospectus (DRHP) with the exchange to raise funds through an Initial Public Offering (IPO).
The KRM Ayurveda Ltd. IPO is a book-built issue comprising only a fresh issue of up to 0.57 crore equity shares. The company proposes to list its equity shares on the NSE SME platform.
Nexgen Capitals Ltd. has been appointed as the book-running lead manager for the issue, while Skyline Financial Services Pvt. Ltd. is acting as the registrar. Key details such as the IPO dates, price band, and lot size are yet to be announced.
₹1350%
Open
HIgh - Low
Previous Close
Total Traded Value
52 Weeks High
52 Weeks Low
Updates On
IPO. Open
IPO. Close
IPO. Price
IPO Market price
| IPO Date | 29 Jan |
| IPO Listing Date | 29 Jan |
| IPO Face Value | ₹10.00 per share |
| IPO Price Range | ₹135.00 |
| IPO Issue Size | 57,40,000 shares |
| IPO Sale Type | Fresh Capital |
| Employee Discount | - |
| IPO Issue Type | Bookbuilding IPO |
| IPO Listing | NSE SME Platform |
| Share Holding Pre Issue | 1,55,20,800 shares |
| IPO Open Date | 21 Jan |
| IPO Close Date | 23 Jan |
| IPO Allotment (Tentative) | 27 Jan |
| Refunds | 28 Jan |
| Credit to Demat Account | 28 Jan |
| IPO Listing Date | 29 Jan |
| Category | Offer |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 35% of the Net Issue |
| Retail Shares Offered | Not less than 15% of the Net Issue |
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | |||
| Retail (Max) | |||
| S-HNI (Min) | |||
| S-HNI (Max) | |||
| B-HNI (Min) |
Incorporated on September 3, 2019, KRM Ayurveda Ltd. operates a network of hospitals and clinics across multiple cities in India and has also established its presence overseas through telemedicine consultations and product sales.
The company is engaged in the manufacturing of Ayurvedic products, including herbal and botanical remedies, medicines, supplements, and wellness and skincare-related items. Currently, KRM Ayurveda runs 6 hospitals and 5 clinics at various locations across the country.
Services and Products
Hospitals
Clinics
Teleconsultation services
KRM Ayurveda products
As of August 31, 2025, the company employs a total of 429 personnel across various departments.
Competitive Strengths
Highly skilled Ayurvedic physicians and certified therapists ensuring quality treatment.
Centralised GMP-certified manufacturing facility ensuring the purity and efficacy of Ayurvedic medicines.
A trusted brand supported by a loyal customer base and strong repeat clientele.
| Assets | 66.79 | 43.91 | 39.48 |
| Total Income | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 12.1 | 3.41 | 7.6 |
| EBITDA | 19.11 | 7.34 | 11.03 |
| NET Worth | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 31.2 | 23.18 | 19.87 |
| ROE | 67.86% |
| ROCE | 43.33% |
| Debt/Equity | 1.31 |
| RoNW | 67.86% |
| PAT Margin | 15.80% |
| EBITDA Margin | 24.96% |
| Price to Book Value | - |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | 13.67 |
| 2 | To meet out the expenses of Working Capital Requirement | 18 |
| 3 | To meet out the General Corporate Purposes; | - |
| 4 | Offer for Sale (OFS) | - |
KRM Ayurveda Ltd. Address
A-16
G T Karnal road
North West Delhi, New Delhi, 110033
+91- 9289101700
compliance@krmayurveda.com
http://www.krmayurvedaindia.com/
IPO Registrar
Skyline Financial Services Pvt.Ltd.
02228511022
ipo@skylinerta.com
https://www.skylinerta.com/ipo.php
The KRM Ayurveda Limited SME IPO opens on 19 January 2026 and closes on 21 January 2026, allowing investors three days to submit their applications.
The IPO is priced in a band of ₹128 to ₹135 per equity share, with a lot size of 1,000 shares, making it suitable for SME-focused investors.
KRM Ayurveda Limited proposes to list its equity shares on the NSE SME platform, providing investors exposure to a growing Ayurvedic healthcare company.
This is a 100% book-built IPO comprising a fresh issue of 57.40 lakh equity shares, aimed at raising growth capital for business expansion.
IPO funds will be used for telemedicine infrastructure, CRM systems, human resources, loan repayment, working capital needs, and general corporate purposes.